Author/Authors :
Kristina Elfgren، نويسنده , , Eva Rylander، نويسنده , , Thomas R?dberg، نويسنده , , Bj?rn Strander، نويسنده , , Anders Strand، نويسنده , , Kirsti Paajanen، نويسنده , , Inga Sjoberg، نويسنده , , Walter Ryd، نويسنده , , Ilvars Silins، نويسنده , , Joakim Dillner and for the Swedescreen Study Group، نويسنده ,
Abstract :
Objective
Evaluation of colposcopic and histopathological findings in women screened for cervical human papillomavirus deoxyribonucleic acid persistence.
Study design
A total of 12 527 women, aged 32 to 38 years old, attending the population-based cervical cancer screening program in Sweden were randomized 1:1 to mock testing or human papillomavirus deoxyribonucleic acid testing by general primer 5+/6+ polymerase chain reaction and subsequent typing. Human papillomavirus deoxyribonucleic acid–positive women with a normal Papanicolaou smear (n = 341) and an equal number from the control group were human papillomavirus tested on average 19 months later. One hundred nineteen women with type-specific human papillomavirus persistence and 111 controls were referred to colposcopy, and 84.8% attended.
Results
Histopathology from colposcopically directed biopsies confirmed cervical intraepithelial neoplasia grade 2 or 3 in 28 of 100 of the women with human papillomavirus deoxyribonucleic acid persistence and in 2 of 95 among controls.
Conclusion
Among women with normal Papanicolaou smear attending population-based screening, the positive predictive value of human papillomavirus deoxyribonucleic acid persistence for detection of biopsy-confirmed cervical intraepithelial neoplasia 2 or 3 was 29%.